Sprycel

Parachute

Biotech

BMS melanoma, genitourinary commercial lead heads to miR

Bristol Myers Squibb's melanoma and GU commercial leader is departing to lead the commercial launch of miR Scientific's first product.

Kyle LaHucik Aug 13, 2021 9:45am

Nurse about to give an infusion

Pressing the pause button on CAR-T with BMS' leukemia drug

Jul 3, 2019 2:00pm

Bristol-Myers Squibb

Improving anti-PD-1 with BMS' popular leukemia drug

Feb 20, 2019 2:00pm